Form 8-K - Current report:
SEC Accession No. 0001564590-22-010212
Filing Date
2022-03-15
Accepted
2022-03-15 07:07:13
Documents
14
Period of Report
2022-03-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K imra-8k_20220315.htm   iXBRL 8-K 40482
2 EX-99.1 imra-ex991_6.htm EX-99.1 133401
3 GRAPHIC g30on1stvq23000001.jpg GRAPHIC 157340
  Complete submission text file 0001564590-22-010212.txt   524326

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA imra-20220315.xsd EX-101.SCH 5673
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE imra-20220315_lab.xml EX-101.LAB 20178
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imra-20220315_pre.xml EX-101.PRE 12019
8 EXTRACTED XBRL INSTANCE DOCUMENT imra-8k_20220315_htm.xml XML 3667
Mailing Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116
Business Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116 617-206-2020
IMARA Inc. (Filer) CIK: 0001672619 (see all company filings)

EIN.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39247 | Film No.: 22739089
SIC: 2834 Pharmaceutical Preparations